Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PACS (PACS) Cash & Equivalents: 2022-2024

Historic Cash & Equivalents for PACS (PACS) over the last 3 years, with FY2024 value amounting to $157.7 million.

  • PACS's Cash & Equivalents rose 61825.36% to $355.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $355.7 million, marking a year-over-year increase of 61825.36%. This contributed to the annual value of $157.7 million for FY2024, which is 11476.79% up from last year.
  • According to the latest figures from FY2024, PACS's Cash & Equivalents is $157.7 million, which was up 11476.79% from $73.4 million recorded in FY2023.
  • PACS's 5-year Cash & Equivalents high stood at $157.7 million for FY2024, and its period low was $58.3 million during FY2022.
  • For the 3-year period, PACS's Cash & Equivalents averaged around $96.5 million, with its median value being $73.4 million (2023).
  • Per our database at Business Quant, PACS's Cash & Equivalents surged by 2599.5% in 2023 and then soared by 11476.79% in 2024.
  • Over the past 3 years, PACS's Cash & Equivalents (Annual) stood at $58.3 million in 2022, then rose by 25.99% to $73.4 million in 2023, then surged by 114.77% to $157.7 million in 2024.
  • Its Cash & Equivalents stands at $157.7 million for FY2024, versus $73.4 million for FY2023 and $58.3 million for FY2022.